Premarket Gainers as of 9:05 am

• DLTH +20% on Q4 earnings.
• IDRA +17% on analyst upgrade.
• PULM +13% on approval of EU patent for its drug delivery technology.
• MBRX +12% on FDA designating Annamycin an Orphan Drug for the treatment of AML.
• OTC:BEBE +12%.
• IDXG +9%.
• RUN +6%.